Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NEXT GEN - PHILIPS OPTIMUS

NCT: NCT07521735 · RECRUITING

NCT IDNCT07521735
StatusRECRUITING
Start Date2026-03-09
Completion2026-04-03

Brief Summary

The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.

Frequently Asked Questions

What is NEXT GEN - PHILIPS OPTIMUS?

NEXT GEN - PHILIPS OPTIMUS is a clinical trial registered under NCT07521735. Current status: RECRUITING.

What is the status of NCT07521735?

The current status of NCT07521735 (NEXT GEN - PHILIPS OPTIMUS) is: RECRUITING.

When did NEXT GEN - PHILIPS OPTIMUS start?

NEXT GEN - PHILIPS OPTIMUS started on 2026-03-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.